Manufacturing Chemist Stand Side with Almac

Published: 6-Nov-2023 Featured companies: Almac Group
Manufacturing Marketing

At the recent CPHI Barcelona trade show Manufacturing Chemist Stand Side caught up with John McQuaid, President and Managing Director of Almac Pharma Services

Taking time out of his busy schedule, John McQuaid spoke to Manufacturing Chemist Stand Side to talk about the company's role and services, why they exhibit at CPHI Barcelona and what their future plans are.

Manufacturing Chemist Stand Side...

'Manufacturing Chemist Stand Side' is a series of exclusive video interviews with leading companies in the pharmaceutical industry, conducted during key market events by our award-winning B2B team.

For more information on how you can be part of 'Manufacturing Chemist Stand Side' contact Don Phares on +44 207 193 3219 or via email don@hpcimedia.com.

Featured companies

The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech...
See more

You may also like

Manufacturing

Almac’s Charnwood facility receives FDA approval for oral dose development and manufacturing

Read more
The facility, which focuses on the manufacture of high potency oral dosage forms, has been approved for use by the FDA

Trending Articles

  1. IMA Life and RheaVita team up to commercialise continuous biopharmaceutical freeze-drying tech The companies will work in tandem to develop and commercialise its continuous freeze-drying technology, allowing the rapid production of complex biopharmaceuticals
  2. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  3. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  4. How flow chemistry is transforming drug discovery New Syrris eBook explores techniques driving efficiency and innovation
  5. Adragos Pharma enhances its sterile injectable production capabilities with new €13m ampoule filling line The novel line at the CDMO's Livron-sur-Drôme site in France will allow the company to manufacture more than 160 million ampoules for sterile injectables annually

Relevant companies

See more

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

Almac’s Charnwood facility receives FDA approval for oral dose development and manufacturing

The facility, which focuses on the manufacture of high potency oral dosage forms, has been approved for use by the FDA
Manufacturing

Almac Sciences awarded Life Sciences Innovative Manufacturing Fund grant

Grant awarded to support the expansion of Almac’s small molecule API manufacturing plant
Manufacturing

BGEN awarded small molecule production facility contract by Almac Sciences

This build will enhance Almac Sciences' active pharmaceutical ingredient (API) production capabilities
Manufacturing

Almac Group releases details of $97m HQ expansion in Northern Ireland

The £80 million expansion has been designed by the pharmaceutical services provider to provide a 140,000 sqft capacity increase for development and manufacturing facilities
Manufacturing

Asynt and Almac team up on bespoke reactor vessels

The two companies have teamed up design and supply a range of bespoke reactor vessels, highlighting the benefits of utilising Asynt's lab vessels to streamline Almac Sciences' scale-up process
Manufacturing

Almac updates software with new content for cancer research

The updates include 16 new gene expression signatures across the Hallmarks of Cancer, improved functionality with online data access and simplified reporting
Manufacturing

Almac launches IXRS3 partnership network

“Managing a mix of technologies throughout the course of a clinical trial is a common pain point for sponsors and service providers."
Subscribe now